Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital, discusses future possibilities for the prevention of chronic obstructive pulmonary disease (COPD) using new biomarker discoveries and genomic technology advancements.
Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital, discusses future possibilities for the prevention of chronic obstructive pulmonary disease (COPD) using new biomarker discoveries and genomic technology advancements.
Transcript
Do you think there might be a future role for predictive biomarkers or genomics for assisting with prevention efforts—for example, if a young adult discloses to their physician that they're vaping and they are told that they have a higher risk for obstructive lung disease later, beyond just their vaping behavior?
I think that's certainly in the cards. I'm not sure that that information alone will change behavior. As you know, behavior modification is complex and difficult. So I'm not confident that information itself would modify teenagers’ behavior or for somebody in their 20s. But nevertheless, these predictive biomarkers that you're talking about are coming down the pike with more research and, frankly, with better technology. So one of the barriers in the past has been our technology was crude. Now with the advent of genomics and multiomics and proteomics and all the other -omics, you know, I think the future is very bright for predictive biomarkers, response biomarkers, therapeutic biomarkers. So I think that is the wave of the future.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More